Complaint conclusion: as noted in the publication, early coverage of drug-eluting stents analyzed by optical coherence tomography: evidence of the impact of stent apposition and strut characteristics on the neointimal healing process.There was one event of a malapposed (under-expanded) stent reported in a pig during baseline procedure for the cypher arm of the study.The product was not returned for analysis.No lot number was supplied therefore a device history record (dhr) review could not be generated.The reported ¿stent under-expanded¿ could not be confirmed as the device was not returned for analysis.The exact cause could not be determined.Vessel characteristics and procedural factors may have contributed to the reported event but are unknown.According to the instructions for use ¿under fluoroscopic visualization, inflate the balloon to at least the nominal pressure to deploy the stent, but do not exceed the labeled rated burst pressure of 16 atm (1621 kpa).Optimal expansion requires the stent to be in full contact with the artery wall, with the stent internal diameter matching the size of the reference vessel diameter.Stent wall contact should be verified through routine angiography or intravascular ultrasound.¿ neither the dhr nor the information available suggests a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken.(b)(4).
|